CEMIP and colonic neoplasm: Surprisingly, 66% of primary colon cancer specimens were negligibly stained with a well-characterized anti-CEMIP antibody (Fig. 1A–1b), which is in contrast to a previous report of bulk colon cancer tissue specimens examined by DNA microarray [24].